Review
Nature Reviews Drug Discovery 5, 1026-1033 (December 2006) | doi:10.1038/nrd2086
Targeting the Hedgehog pathway in cancer
Lee L. Rubin1 & Frederic J. de Sauvage2 About the authors
Abstract
Several key signalling pathways, such as Hedgehog, Notch, Wnt and BMP–TGF
–Activin (bone morphogenetic protein–transforming growth factor-
–Activin), are involved in most processes essential to the proper development of an embryo. It is also becoming increasingly clear that these pathways can have a crucial role in tumorigenesis when reactivated in adult tissues through sporadic mutations or other mechanisms. We will focus here on the Hedgehog pathway, which is abnormally activated in most basal cell carcinomas, and discuss potential therapeutic opportunities offered by the progress made in understanding this signalling pathway.
- View At a Glance
Author affiliations
- Harvard Stem Cell Institute, Biolabs, Room 150, 16 Divinity Avenue, Cambridge, Massachusetts 02138, USA.
- Department of Molecular Biology, Genentech, Inc., South San Francisco, California 94080, USA.
Correspondence to: Lee L. Rubin1 Email: lrubin@mcb.harvard.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Agonizing HedgehogNature Chemical Biology News and Views (01 Jan 2006)
Polarity, proliferation and the hedgehog pathwayNature Genetics News and Views (01 Nov 1996)
RESEARCH
Hypothetical biotechnology mega-mergersNature Biotechnology Strategic Planning (01 May 1999)
Hypothetical biotechnology mega-mergersNature Biotechnology Strategic Planning (01 May 1999)
See all 56 matches for Research

